Aerska
Dublin, Ireland · Biotechnology, Health Care, Medical
Aerska is a biotechnology company developing RNA medicines to treat, delay, and prevent diseases of the brain. The company is leveraging advances in ‘brain shuttles’ to enable targeted delivery of next-generation RNAi therapeutics to the CNS. Aerska is headquartered in Dublin, Ireland, with research operations in London, UK.
Key facts
- Headquarters
- Dublin, Ireland
- Employees
- 20
- Industries
- Biotechnology, Health Care, Medical
- Status
- Private
- Website
- aerska.com
- Company page
Recent activity at Aerska
- : Aerska, a Dublin-based biotechnology startup, raised €32 million in Series A funding led by EQT Dementia Fund and age1 to advance its RNA medicine platform.
- : Aerska raised $39 million, bringing its total investment to $60 million, as it becomes a standout in the tech funding landscape of Q1 2026.
- : Aerska Raises $39M Series A Financing led by EQT Dementia Fund and age1 to deliver RNA Medicines to the Brain.
- : Aerska has raised $21 million in seed funding to develop RNA-interfering molecules to treat Alzheimer's and Parkinson's diseases. The Dublin-based startup emerged from stealth with 15 employees.
Aerska funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2026 | Series A | $32.0M |
| May 2026 | Venture | $39.0M |
| Feb 2026 | Series A | $39.0M |
| Oct 2025 | Seed | $21.0M |
Leadership
- Jack Om, CEO, Co-founder
- Stuart Milstein, Chief Platform Officer and Co-Founder
- Andrew Cregan, Director, Head of Finance and Administration
- Jack O'Meara, Founder
- David Hardwicke, Founder
Verified email and direct lines for Aerska’s decision-makers are on Fundz. See plans
Aerska in the news
- Biotech doubles financing in quest to silence genes behind neurological diseases - STAT (Feb 09, 2026)
- Aerska Strengthens Leadership and Board with Key Appointments to Advance Systemically Delivered RNA Medicines for the Brain - Yahoo Finance (Apr 15, 2026)
- Aerska Launches with $21 Million in Financing to Develop RNAi Medicines for Diseases of the Brain - GlobeNewswire (Oct 01, 2025)
- EQT Life Sciences co-leads USD 39 million Series A in Aerska to help systematically deliver RNA medicines to the brain - Cision News (Feb 09, 2026)
- Irish biotech launches with $21M to shuttle RNAi meds to brain - fiercebiotech.com (Oct 01, 2025)
- Irish startup launches with plan to use 'shuttles' to get RNAi into brain - FirstWord Pharma (Oct 01, 2025)
- Irish biotech Aerska out from stealth with $21m for neurology therapies - siliconrepublic.com (Oct 01, 2025)
- Aerska Raises $39M Series A Financing led by EQT Dementia Fund and age1 to Systemically Deliver RNA Medicines to the Brain - Yahoo Finance (Feb 09, 2026)
Companies similar to Aerska
- Lifesenz Cancer Research Labs Private Limited · Biotechnology, Health Care, Medical, Therapeutics
- Vyome Holdings · Biotechnology, Health Care, Medical, Therapeutics
- SymPhysis Medical · Biotechnology, Health Care, Medical, Therapeutics
- NRx Pharmaceuticals · Biotechnology, Health Care, Medical, Therapeutics
- Citius Oncology · Biotechnology, Health Care, Medical, Therapeutics
About Aerska: questions and answers
What does Aerska do?
Aerska is a biotechnology company developing RNA medicines to treat, delay, and prevent diseases of the brain. The company is leveraging advances in ‘brain shuttles’ to enable targeted delivery of next-generation RNAi therapeutics to the CNS. Aerska is headquartered in Dublin, Ireland, with research operations in London, UK.
Where is Aerska headquartered?
Aerska is headquartered in Dublin, Ireland.
How many employees does Aerska have?
Aerska has about 20 employees.
Has Aerska raised funding?
Yes. Fundz has recorded 4 funding events for Aerska. The most recent, Series A of $32.0M, was in Sep 2026.
Who leads Aerska?
Jack Om is a CEO, Co-founder at Aerska.
What is the latest news on Aerska?
On Sep 01, 2026, Aerska, a Dublin-based biotechnology startup, raised €32 million in Series A funding led by EQT Dementia Fund and age1 to advance its RNA medicine platform.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy